Global secretome characterization of herpes simplex virus 1-infected human primary macrophages

Juho J Miettinen1, Sampsa Matikainen, Tuula A Nyman

  • 1Institute of Biotechnology, University of Helsinki, Helsinki, Finland.

Journal of Virology
|September 14, 2012
PubMed

Insights

Herpes simplex virus 1 (HSV-1) infection activates macrophages to secrete proteins, many via exosomes. This antiviral defense mechanism involves interferon-induced proteins but HSV-1 blocks interleukin-1β release.

Area of Science:

  • Immunology
  • Virology
  • Proteomics

Background:

  • Herpes simplex virus 1 (HSV-1) is a widespread pathogen.
  • Macrophages are key cells in the innate immune response to viral infections.

Purpose of the Study:

  • To characterize the protein secretion (secretome) of human macrophages in response to HSV-1 infection.
  • To investigate the role of interferon-beta (IFN-β) priming in modulating the macrophage secretome during HSV-1 infection.

Main Methods:

  • High-throughput quantitative proteomics was used to analyze the secretome of HSV-1-infected human primary macrophages.
  • Bioinformatics analysis was performed on the identified proteins.

Main Results:

  • 516 human proteins were identified in the macrophage secretome upon HSV-1 infection.
  • Secretion of 411 proteins increased >2-fold with IFN-β priming and/or HSV-1 infection.
  • 80% of highly secreted proteins were exosomal, indicating activation of nonclassical, vesicle-mediated secretion.
  • Secreted proteins included immune response factors, interferon-induced proteins (e.g., IFIT2, IFIT3, STAT1, MxA), and danger signal proteins.
  • Interleukin-1β was not released, suggesting HSV-1 antagonizes inflammasome activity.

Conclusions:

  • HSV-1 infection and IFN-β priming induce a significant, nonclassical secretion of proteins from macrophages.
  • Secreted interferon-induced proteins may possess extracellular antiviral functions.
  • HSV-1 actively inhibits inflammasome activation by preventing interleukin-1β release.